Cellecta, Inc.
Alex Chenchik is the President of Cellecta, Inc. They previously worked as a Visiting Scientist at Harvard School of Public Health from 2011 to 2016. Prior to that, they served as the Research and Development Director of Gene Cloning Analysis at BD from 2000 to 2004, and held various director positions at Clontech and BD Biosciences Clontech from 1994 to 2003.
This person is not in any teams
Cellecta, Inc.
1 followers
Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets. We offer pooled lentiviral shRNA and CRISPR libraries, pooled library screening and analysis by NGS, targeted RNA-Seq for biomarker discovery, lentiviral reagents, and stable cDNA, shRNA, and CRISPR constructs and isogenic cell lines.